UK markets close in 2 hours 40 minutes

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
151.00-3.51 (-2.27%)
At close: 04:00PM EST
151.00 0.00 (0.00%)
Pre-market: 07:14AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 9.80B
Enterprise value 14.72B
Trailing P/E N/A
Forward P/E 9.12
PEG ratio (5-yr expected) 4.00
Price/sales (ttm)2.73
Price/book (mrq)3.57
Enterprise value/revenue 4.11
Enterprise value/EBITDA 16.83

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 35.45%
S&P500 52-week change 3-8.57%
52-week high 3169.98
52-week low 3125.36
50-day moving average 3155.50
200-day moving average 3150.49

Share statistics

Avg vol (3-month) 3546.38k
Avg vol (10-day) 3424.3k
Shares outstanding 562.97M
Implied shares outstanding 6N/A
Float 861.22M
% held by insiders 12.51%
% held by institutions 196.92%
Shares short (12 Jan 2023) 42.63M
Short ratio (12 Jan 2023) 44.04
Short % of float (12 Jan 2023) 44.78%
Short % of shares outstanding (12 Jan 2023) 44.17%
Shares short (prior month 14 Dec 2022) 42.23M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin -0.52%
Operating margin (ttm)27.02%

Management effectiveness

Return on assets (ttm)5.30%
Return on equity (ttm)-0.56%

Income statement

Revenue (ttm)3.58B
Revenue per share (ttm)57.66
Quarterly revenue growth (yoy)12.20%
Gross profit (ttm)2.88B
EBITDA 1.62B
Net income avi to common (ttm)-18.69M
Diluted EPS (ttm)-7.37
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)899.36M
Total cash per share (mrq)14.28
Total debt (mrq)5.81B
Total debt/equity (mrq)211.81
Current ratio (mrq)3.16
Book value per share (mrq)43.65

Cash flow statement

Operating cash flow (ttm)1.11B
Levered free cash flow (ttm)1.54B